AGYTF
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Jul 21 closing price
Capitalization
543.88M
YCBD
Price
$0.76
Change
-$0.09 (-10.59%)
Updated
Aug 15 closing price
Capitalization
6.74M
Interact to see
Advertisement

AGYTF vs YCBD

Header iconAGYTF vs YCBD Comparison
Open Charts AGYTF vs YCBDBanner chart's image
Allergy Therapeutics
Price$0.09
Change-$0.00 (-0.00%)
Volume$300
Capitalization543.88M
CBDMD
Price$0.76
Change-$0.09 (-10.59%)
Volume$219.62K
Capitalization6.74M
AGYTF vs YCBD Comparison Chart in %
Loading...
YCBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGYTF vs. YCBD commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGYTF is a Hold and YCBD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (AGYTF: $0.09 vs. YCBD: $0.76)
Brand notoriety: AGYTF and YCBD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AGYTF: 47% vs. YCBD: 256%
Market capitalization -- AGYTF: $543.88M vs. YCBD: $6.74M
AGYTF [@Pharmaceuticals: Generic] is valued at $543.88M. YCBD’s [@Pharmaceuticals: Generic] market capitalization is $6.74M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGYTF’s FA Score shows that 1 FA rating(s) are green whileYCBD’s FA Score has 1 green FA rating(s).

  • AGYTF’s FA Score: 1 green, 4 red.
  • YCBD’s FA Score: 1 green, 4 red.
According to our system of comparison, both AGYTF and YCBD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

YCBD’s TA Score shows that 3 TA indicator(s) are bullish.

  • YCBD’s TA Score: 3 bullish, 6 bearish.

Price Growth

AGYTF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while YCBD (@Pharmaceuticals: Generic) price change was -14.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGYTF($544M) has a higher market cap than YCBD($6.74M). AGYTF YTD gains are higher at: 63.462 vs. YCBD (-74.793).
AGYTFYCBDAGYTF / YCBD
Capitalization544M6.74M8,075%
EBITDAN/A1.68M-
Gain YTD63.462-74.793-85%
P/E RatioN/A1.48-
RevenueN/A19.6M-
Total CashN/A1.77M-
Total DebtN/A1.15M-
FUNDAMENTALS RATINGS
AGYTF vs YCBD: Fundamental Ratings
AGYTF
YCBD
OUTLOOK RATING
1..100
3055
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
4391
P/E GROWTH RATING
1..100
569
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

YCBD's Valuation (64) in the Other Consumer Services industry is in the same range as AGYTF (90) in the null industry. This means that YCBD’s stock grew similarly to AGYTF’s over the last 12 months.

YCBD's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as AGYTF (100) in the null industry. This means that YCBD’s stock grew similarly to AGYTF’s over the last 12 months.

AGYTF's SMR Rating (94) in the null industry is in the same range as YCBD (100) in the Other Consumer Services industry. This means that AGYTF’s stock grew similarly to YCBD’s over the last 12 months.

AGYTF's Price Growth Rating (43) in the null industry is somewhat better than the same rating for YCBD (91) in the Other Consumer Services industry. This means that AGYTF’s stock grew somewhat faster than YCBD’s over the last 12 months.

AGYTF's P/E Growth Rating (5) in the null industry is somewhat better than the same rating for YCBD (69) in the Other Consumer Services industry. This means that AGYTF’s stock grew somewhat faster than YCBD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGYTFYCBD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
27%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
25%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
77%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
YCBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHSX37.130.56
+1.53%
Hartford Healthcare R4
JETAX17.130.02
+0.12%
abrdn Focused Em Markets ex-China A
FMXSX8.25N/A
N/A
Federated Hermes Max-Cap Index Svc
PSBJX25.77-0.11
-0.43%
Principal SmallCap J
GLIFX17.72-0.63
-3.43%
Lazard Global Listed Infrastructure Inst

AGYTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGYTF has been loosely correlated with YCBD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AGYTF jumps, then YCBD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGYTF
1D Price
Change %
AGYTF100%
N/A
YCBD - AGYTF
39%
Loosely correlated
-10.98%
SDZXF - AGYTF
20%
Poorly correlated
+2.12%
PRFX - AGYTF
0%
Poorly correlated
-4.93%
APNHF - AGYTF
0%
Poorly correlated
N/A
ARSUF - AGYTF
0%
Poorly correlated
N/A
More

YCBD and

Correlation & Price change

A.I.dvisor indicates that over the last year, YCBD has been loosely correlated with AGYTF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if YCBD jumps, then AGYTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YCBD
1D Price
Change %
YCBD100%
-10.98%
AGYTF - YCBD
39%
Loosely correlated
N/A
TLRY - YCBD
25%
Poorly correlated
-12.71%
DERM - YCBD
23%
Poorly correlated
-4.27%
CRON - YCBD
23%
Poorly correlated
-5.95%
SXTC - YCBD
21%
Poorly correlated
+1.27%
More